The Logistics Coordination Forum (LCF) is a platform to prepare, review, revise, and update the needs of contraceptives and the medical surgical requisite (MSR), consumption trends, stock status, pipeline positions, procurement status, SCM issues, etc., and to suggest capacity building and system improvements in the areas of procurement, storage, and supply management for DGFP.
Improving Supply Chain Management in the DGFP in Bangladesh through the Logistics Coordination Forum
The purpose of this SOP is to describe the procedures and activities of ADRAC in the review and evaluation of ADE reports received by ADRMC. It is applicable to all ADE reports received for medicinal products, including Unani, Ayurvedic, herbal, homeopathic and biochemical systems of drugs, vaccines, and biological products.
The purpose of this SOP is to outline the management of spontaneous reporting of ADEs by the ADRMC. It is applicable to medicinal products, including Unani, Ayurvedic, herbal, homeopathic, and biochemical systems of drugs, vaccines, and biological products. The SOP has been written to describe the procedures to be used by ADRMC members to collect, record, review, and manage ADE reports received by the PV center.
The purpose of this SOP is to provide guidance to DGDA officials on the steps required to conduct PMS of medicinal products available in retail and wholesale pharmacies, drug shops, and outlets. It is applicable to medicinal products, including traditional complementary and alternative medicines (TCAM), vaccines, and biological products.
Keep Maternal, Newborn, and Child Health Medicines Safe: Introducing MNCH commodities into a pharmacovigilance system
As countries aim to achieve the Sustainable Development Goals, there is an emphasis on increasing the availability of medicines. However, poor quality products or dispensing methods may decrease treatment effectiveness or even result in patient death. ADEs negatively affect patient care and increase costs to the system. A functioning PV system monitors these events and triggers actions to minimize their impact. While some disease-specific areas, such as tuberculosis, have made PV a regular tenant of their treatment programs, medicines used for maternal, newborn, and child health (MNCH) are often ignored in reporting. This case study highlights steps taken to ensure the safe use of medicines for mothers, newborns, and children through regular adverse drug event (ADE) reporting as part of the national pharmacovigilance (PV) program in Bangladesh.
Project dates: 2011-2018
SIAPS and its predecessor programs have assisted numerous countries in strengthening governance to promote robust decision making, enhance accountability, reduce opportunities for corruption, and improve efficiencies to enable better access to and use of quality-assured medicines. This compendium draws on these experiences and provides a collection of examples of strategies and approaches for strengthening governance in pharmaceutical systems. The compendium highlights accumulated insights into factors that may have enabled or constrained the success of governance improvement initiatives. The intention is to systematically bolster knowledge, in alignment with USAID’s collaborating, learning, and adapting approach, so that stakeholders may examine the applicability of lessons learned and apply them in different settings to maximize resources and attain better development results. The compendium begins by defining governance, then explains its importance in pharmaceutical systems and introduces the framework SIAPS has used to guide its governance strengthening activities. It presents eight case studies on SIAPS’ work in enhancing governance in pharmaceutical systems, summarizes challenges commonly encountered and lessons learned, and closes with some reflections on the usefulness of SIAPS’ governance-strengthening framework.
Since September 2011, SIAPS has partnered with Bangladesh’s Ministry of Health and Family Welfare (MOHFW) and its key Directorates, including the Directorate General of Family Planning (DGFP); the Directorate General of Health Services (DGHS), the Directorate General of Drug Administration; and the National Tuberculosis Control Program, to address barriers to access to essential health commodities […]
In Bangladesh, the Ministry’s Procurement and Logistics Management Cell (PLMC) made an assessment of the status of medical equipment that was no longer usable and explored the logistics in health facilities across the country to accelerate the disposal process. The PLMC and SIAPS conducted seven divisional workshops on condemnation of medical and non-medical items for all district- and sub-district-level health managers under the MoHFW to share the assessment findings, the disposal process, and how that process could be improved for effective logistics management as part of a hospital management system.
There has been a long‐recognized need of Central Medical Stores Depot (CMSD) staff for a complete collection of documents representing the up‐to‐date warehouse management
standard operating procedures (SOPs) of CMSD: there was no such resource capturing all the
operational procedures, circulars, registers, office orders, and so on used in the different sections
involved in CMSD’s logistical activities. In answer to this need, CMSD management has taken the initiative to develop a single volume containing all the required documents they have been adopted into existing procedures over the years of operation.
- The Use of Pharmaceutical Information for Decision Making in Namibia's National ART Program: Assessment Report
SIAPS conducted this assessment to determine the extent to which pharmaceutical information generated from the Electronic Dispensing Tool (EDT) and […]
The Directorate of Drugs and Medical Supplies (DDMS) plays a key role in providing technical guidance and setting strategic direction […]
- Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program Inventory of Key Technical Resources
The main purpose of this inventory is to serve as a reference to help stakeholders working in the pharmaceutical sector […]